SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-115096
Filing Date
2022-04-22
Accepted
2022-04-22 16:06:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d283935ddefa14a.htm DEFA14A 11291
2 GRAPHIC g283935g22m22.jpg GRAPHIC 224578
3 GRAPHIC g283935g33m33.jpg GRAPHIC 46112
  Complete submission text file 0001193125-22-115096.txt   370916
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39692 | Film No.: 22845496
SIC: 2836 Biological Products, (No Diagnostic Substances)